Prostate MRI teleradiology with PI-RADS reporting

Prostate MRI teleradiology at AstraRad means a multiparametric study is read by a board-certified body imaging subspecialist and returned as a final signed report carrying a PI-RADS assessment category for every lesion described, with the sector location and the measurement a fusion biopsy needs. Multiparametric prostate MRI defaults to the routine tier, 24 to 48 hours from last-image arrival to radiologist signature, and any study can be submitted STAT. Every read is priced per report with no minimums.

This page is written for the urology practice or imaging center that has the scanner and the protocol working, and needs the reporting half to be as standardized as the acquisition. A prostate MRI report is a referral document before it is anything else: a urologist reads it to decide whether to biopsy, where to aim, and whether to keep a man on surveillance for another cycle. That decision travels on a number and a location, and both of them have to be there.

What is PI-RADS and why does the score matter?

PI-RADS, the Prostate Imaging Reporting and Data System, is the structured standard for assessing multiparametric prostate MRI. It is published by the American College of Radiology with the European Society of Urogenital Radiology and the Admetech Foundation, and the current release is version 2.1, issued in 2019 as an update to version 2 and published in European Urology.

The score matters because it converts a paragraph of impression prose into a category a urologist can act on without having to reconstruct the radiologist's reasoning. Each suspicious finding gets one assessment category:

Category	What it means
PI-RADS 1	Clinically significant cancer is highly unlikely
PI-RADS 2	Clinically significant cancer is unlikely
PI-RADS 3	Equivocal, the presence of clinically significant cancer is uncertain
PI-RADS 4	Clinically significant cancer is likely
PI-RADS 5	Clinically significant cancer is highly likely

The categories are reached by a defined rule, which is what makes them portable between readers. Diffusion-weighted imaging with its apparent diffusion coefficient map is the dominant sequence in the peripheral zone. T2-weighted imaging is dominant in the transition zone. Dynamic contrast enhancement is the tiebreaker that resolves an equivocal peripheral zone finding one way or the other. A report that hands back a category without naming the version it was scored against, or without saying which sequence carried the assessment, has given a urologist a number they cannot audit.

Two honest limits belong on this page. PI-RADS v2.1 is written for detecting clinically significant cancer in men who have not been treated, so it is not the instrument for post-treatment surveillance or for staging a cancer already known. And a category is a probability statement about a lesion, so it informs a biopsy decision alongside PSA density, digital rectal exam, family history, and the patient's own preferences. The National Cancer Institute's prostate screening summary is a reasonable primer for the surrounding clinical picture.

What a structured prostate MRI report contains

A prostate MRI report earns its place by being usable at three separate desks: the urology clinic, the biopsy suite, and the multidisciplinary meeting. Every report our body imaging subspecialists sign carries the same sections in the same order.

• Technique, naming the field strength, the sequences acquired, and whether contrast was given.
• Prostate volume, measured, with PSA density calculated when the PSA value is supplied with the order.
• Lesion-by-lesion findings, each with its sector map location, its zone, its largest dimension in millimeters, its score on the dominant sequence, and its overall PI-RADS assessment category.
• The index lesion identified explicitly, so a fusion biopsy operator knows which target to prioritize.
• Local staging features: extraprostatic extension, seminal vesicle invasion, neurovascular bundle involvement.
• Everything else in the field of view: pelvic nodes, bones, bladder, and incidental findings that need their own follow-up.
• Impression, stating the highest category present, the index lesion location, and what the study can and cannot answer.

The sector map and the measurement are the two items most often missing from an outside report, and they are the two that decide whether the study can drive a targeted biopsy at all. "Suspicious lesion in the left peripheral zone" sends an operator hunting. "13 mm lesion, left posterolateral peripheral zone, mid gland, PI-RADS 4, index lesion" gives them a target. Structured reporting by study type is standing practice across the panel, described in more depth in subspecialty reads by study type.

Who should read a prostate MRI

A body imaging subspecialist. Prostate MRI is abdominopelvic cross-sectional work, and it routes on modality and body part to the same fellowship-trained readers who take liver, rectal, and MR enterography studies, out of a panel of board-certified subspecialists across ten subspecialties on panel.

Three specific problems explain why the routing rule matters more here than the general subspecialty argument does. Benign prostatic hyperplasia produces transition zone nodules that imitate tumor on T2, and telling a well-encapsulated nodule from a lenticular non-circumscribed lesion is pattern recognition built from volume. Post-biopsy hemorrhage darkens the peripheral zone on T2 and distorts the ADC, which is why the interval since biopsy belongs on the requisition and in the report. And the equivocal peripheral zone finding, the PI-RADS 3 that dynamic contrast enhancement either upgrades or leaves alone, is the exact call that separates a reader who reads prostates weekly from one who reads them occasionally.

No algorithm reads any part of the study. AstraRad performs no AI pre-read, no AI triage, and no AI drafting on prostate MRI or on anything else. The subspecialist reviews every sequence and the assessment category is their judgment against the published rule, which is the answer your quality committee will want when it asks how a category was reached.

One in twenty signed reports is pulled into an independent blind double-read by a second subspecialist in the same anatomy. Every discrepancy is reviewed at a monthly meeting and closed with the reader who signed. The protocol sits on our published SLA. The wider routing and governance mechanics, including intake and report delivery, are set out in how a study becomes a signed report.

Prior studies and active surveillance

Send the priors. A surveillance report exists to answer one comparative question, whether the index lesion changed, and a reader without the earlier images and the earlier report in view cannot answer it. Priors travel down the same DICOM route or the same portal upload as the current study, and the reader opens them as part of the interpretation.

Serial reporting has its own published framework. PI-RADS scores a study; the PRECISE recommendations, updated to version 2 in 2024, score the change between studies for men on active surveillance. Practices differ on which they ask for on a surveillance report, and some ask for both, so tell us at onboarding which your urologists have standardized on and the reports come back in that shape from the first study.

Continuity is a routing decision. Serial studies for the same patient go to the same subspecialty, and where the original reader is on shift they go back to the physician who read the baseline. Coverage is 24/7/365 on scheduled US shifts, so a Saturday acquisition does not wait for Monday to find a body imaging reader. Prostate work that moves into staging or restaging with PET-CT reaches nuclear and oncologic imaging subspecialists on the same panel, described on PET-CT teleradiology reads.

How fast does a prostate MRI report come back?

Multiparametric prostate MRI defaults to routine, contracted at 24 to 48 hours, measured from the arrival of the last image of the study to the radiologist signing the final report. STAT is under 4 hours, 2-hour and 1-hour STAT are available on request at a higher multiplier, and any study can be submitted at any tier.

Scenario	Tier	Commitment
Detection or staging MRI ahead of a clinic visit	Routine	24 to 48 hours
Surveillance interval study	Routine	24 to 48 hours
Inpatient or same-day surgical planning	STAT	Under 4 hours
A patient waiting on the answer to keep a slot	STAT, faster on request	Under 4 hours (2h or 1h on request)

Prostate MRI is rarely an emergency, so the tier that decides whether a urology practice can run a clean pathway is the routine one. A predictable report inside 48 hours is what lets the biopsy slot hold and the results conversation stay on the calendar it was booked for. Routine is contracted at 24 to 48 hours. How the clock starts, what counts as a miss, and what the remedy is are published in full on the SLA and QA methodology page.

Every report is final. There is no preliminary tier here on any modality, including overnight, so nobody on your side re-reads a prostate MRI in the morning to make it billable. If the distinction matters to your billing or credentialing workflow, preliminary vs final radiology reads covers the mechanics. Studies move under encrypted transfer built to the HIPAA Security Rule safeguard categories on a DICOM conformant platform, with signed reports returned over HL7 or FHIR into your RIS or EHR; the specifics are on our compliance and security posture.

What does a prostate MRI read cost?

Per report, with no minimums, no ceilings, no subscription, and no platform fee. Multiparametric prostate MRI sits in the advanced MRI class on the rate card, because three sequence families and a lesion-by-lesion assessment consume more subspecialist reading time than a single-sequence extremity study. Each faster STAT speed carries its own multiplier, printed on the card before you send anything and itemized on every invoice line.

Volume and case mix move the number enough that a public list price would mislead a low-volume practice and a high-volume one in opposite directions. Ours goes in writing when you ask: request a volume quote and a complete per-report rate card lands within one business day. The full model, all four printed rules, is on the per-report pricing page.

What a urology practice should ask for

Any vendor can say they report PI-RADS. These eight questions separate the ones that do it in a form your biopsy operator can use. Ask them of us and of anyone else on the list.

1. Which PI-RADS version do your reports state? The version belongs in the report, not in the sales deck.
2. Does every lesion carry a sector map location and a measurement in millimeters? Without both, targeted biopsy is guesswork.
3. Is the index lesion identified explicitly? A report with three lesions and no priority ranking pushes the decision back to the clinic.
4. How is an equivocal peripheral zone finding handled? You want the dynamic contrast enhancement rule described, not implied.
5. Who signs, and what is their fellowship? Ask for it by subspecialty, and ask for the credential file during procurement.
6. Are priors read as part of the interpretation, and at what cost? Comparison should be part of the read.
7. Where does the turnaround clock start? Last-image arrival to signature is the only definition that cannot be gamed.
8. Is the report final or preliminary? A preliminary read means your own group produces the billable interpretation a second time.

Send a batch of ten prostate MRIs across the range your clinic sees, including two surveillance intervals and one post-biopsy study, and put the reports in front of the urologists who have to act on them. Ten reports settle the question faster than any page describing them. Prostate MRI is one line inside a wider MRI service; MRI teleradiology reporting covers the rest of the anatomy, and our service lines covers the rest of the modality mix.